
The nutrients in the MRK have been clinically tested for their oral bioavailability and also for their safety and efficacy in activating PGC-1α and upstream cellular signaling cascades, These actions mimic the protective effects of exercise and caloric restriction on mitochondrial biogenesis, metabolic fitness, and aging. The key signaling cascades affected include those involving nitric oxide (Nitric Oxide Support), SIRT1 (Resveratrol Plus), and AMPK (Alpha Lipoic Acid). Ultimately, it is the stimulation of these cascades that leads to activation of PGC- 1α and subsequent upregulation of mitochondrial biogenesis and promotion of overall metabolic fitness. For optimal benefit, combine this product with a healthy diet and exercise regimen.*
Nitric Oxide Support is a patented, extended-release formulation containing arginine alpha-ketoglutarate and ACTINOS2®, a proprietary whey peptide fraction. This synergistic combination serves as an effective nitric oxide (NO) precursor. As a vasodilator, NO exerts a protective effect on blood vessel endothelium.[7] Within the cell, NO plays an important role in intracellular communication, acting as a trigger for mitochondrial biogenesis.*[8]
Resveratrol Plus provides a distinctive bioflavonoid complex with resveratrol, quercetin, and pterostilbene (bio-optimized methylated resveratrol).[9] These three antioxidants work together synergistically and are being extensively studied in the areas of cardiovascular health and aging.*
Alpha Lipoic Acid is a multifunctional antioxidant that has the ability to neutralize free radicals in both the aqueous-based and lipid-based environments of cells. In addition, Alpha Lipoic Acid’s patented, controlled-release formulation provides extended protection[10] by promoting synthesis of glutathione and “recharging” other important antioxidants such as vitamin C, vitamin E, and coenzyme Q10.*
An independent study of the MRK was performed. A report of the study, written by Dr. Joseph Evans and entitled “A Three-Month, Open- Label Pilot Clinical Study Evaluating the Efficacy of the Mitochondrial Revolution on Aerobic Conditioning and Body Composition,” is available through your Revolution Health & Wellness Clinic Functional Medicine Consultant.*
Directions
We recommend 1 packet twice daily for the first 60 days then decrease to 1 packet daily. Take the first packet first thing in the morning (away from meals – 1 hour before or 2 hours after) and the 2nd packet before 2pm as it can be activating and decrease sleep.
References
- Goffart S, Wiesner RJ. Regulation and co-ordination of nuclear gene expression during mitochondrial biogenesis. Exp Physiol. 2003 Jan;88(1):33-40. Review. [PMID: 12525853]
- López-Lluch G, Irusta PM, Navas P, et al. Mitochondrial biogenesis and healthy aging. Exp Gerontol. 2008 Sep;43(9):813-9. Review. [PMID: 18662766]
- Lanza IR, Short DK, Short KR, et al. Endurance exercise as a countermeasure for aging. Diabetes. 2008 Nov;57(11):2933-42. [PMID: 18716044]
- Johnston AP, De Lisio M, Parise G. Resistance training, sarcopenia, and the mitochondrial theory of aging. Appl Physiol Nutr Metab. 2008 Feb;33(1):191-9. Review. [PMID: 18347672]
- Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005;39:359-407. [PMID: 16285865]
- Leone TC, Lehman JJ, Finck BN, et al. PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol. 2005 Apr;3(4):e101. [PMID: 15760270]
- Bian K, Doursout MF, Murad F. Vascular system: role of nitric oxide in cardiovascular diseases. J Clin Hypertens (Greenwich). 2008 Apr;10(4):304-10. [PMID: 18401228]
- Nisoli E, Carruba MO. Nitric oxide and mitochondrial biogenesis. J Cell Sci. 2006 Jul 15;119(Pt 14):2855-62. [PMID: 16825426]
- Wen X, Walle T. Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metab Dispos. 2006 Oct;34(10):1786-92. [PMID: 16868069]
- Teichert J, Kern J, Tritschler HJ, et al. Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers. Int J Clin Pharmacol Ther. 1998 Dec;36(12):625-8. [PMID: 9876998]